Houseviews: Trading tips on four stocks ahead of weekend
Published on Thu, May 31, 2012 at 00:00 | Source :
BIOCON
Brokerage: Merrill Lynch
Rating: DOWNGRADED
Target: Rs 260
Rationale: Base business outlook is weaker due to increased competition in bio-pharma and lower licensing income.